AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it ...

“In February 2021, Prime Minister Modi supplied Dominica with 70,000 doses of the AstraZeneca COVID-19 vaccine — a generous ...

"Slingshot represents an opportunity to bridge the gap between academic innovation and clinical development of a novel ...

While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

Astrazeneca has recently announced 3.5 billion dollars of capital investment in the United States focused on expanding the ...

Bernstein analyst Justin Smith maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of p18,000.00. Justin Smith has given his Buy rating due to a combination of ...

AstraZeneca PLC aims for $80 billion revenue by 2030 through strong growth in oncology, biopharmaceuticals, and rare diseases ...

AstraZeneca Plc is increasingly looking to the US for growth as its once fast-expanding China business faces challenges amid ...

AstraZeneca (GB:AZN) has released an update. AstraZeneca’s Senior Independent Non-Executive Director, Philip Broadley, has made a notable ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

Cambridge, England-based biopharmaceutical giant AstraZeneca is pouring billions of dollars into properties in the United ...

Symptom screening improved symptom scores among children with cancer compared with usual care, two randomized trials showed.